
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €334.0m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€18.94
7D
0.9%
1Y
-36.0%
MPH Health Care
Market Cap: €102.3m
An investment company, engages in the healthcare business in Germany.
93M1
€23.60
7D
-1.3%
1Y
33.7%
Novogenia
Market Cap: €80.4m
Manufactures and sells personalized health products in global markets.
7V0
€6.70
7D
0%
1Y
-8.2%
Cantourage Group
Market Cap: €70.1m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€5.62
7D
2.2%
1Y
39.1%